Welcome to our new friends across the pond – the Builds Bio+ London/UK chapter!? This partnership is a major milestone in Builds Bio+’s evolution into an international organization, creating a dynamic ecosystem that harnesses the strengths of the UK and US life sciences markets. This expansion unites 11 founding members from industry, government, and academia to drive innovation and growth across the UK and Europe, while building stronger transatlantic ties with the Greater New York and Philadelphia regions. Learn more:?https://lnkd.in/ekvrhwRb In a keynote address,?Professor Sir Robert Lechler?of King's College London underscored the tremendous potential of this partnership to advance scientific progress and innovation in healthcare globally. A follow-up panel, moderated by Ryan Matenchuk, CEO, Galileo Labs, presented findings from the 2024 London Study Tour, which saw life sciences leaders from London and NYC come together to visit and learn more about life science projects and new developments in the vibrant areas of London, Oxford and Cambridge. Panelists Justin Cratty, Chief Scientific Experience Officer, Galileo Labs, Faaiza Lalji, Director of Planning & Development, Precis Advisory Ltd., Bennett John, Senior Capital Investment Officer, British Consulate General New York, and Daniel Clark,?Vice President and Director?New York City Economic Development Corporation shared insights from recent exchanges between these thriving life sciences hubs. View the report here:?https://lnkd.in/ekvrhwRb We’re excited to see the impact this collaboration will have on the global life sciences field! If you’re at the symposium, we’d love to hear your thoughts and key takeaways—drop them in the comments below! #NYMBuildsBio?#NYMSymposium?#LifeSciences #Innovation #EconomicDevelopment?
-
+4